Predicting the future of breast cancer
- 1 January 2003
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 9 (1), 16-18
- https://doi.org/10.1038/nm0103-16
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Cyclin E and Survival in Patients with Breast CancerNew England Journal of Medicine, 2002
- Regulation of CDC6, Geminin, and CDT1 in Human Cells that Undergo PolyploidizationMolecular Biology of the Cell, 2002
- Metastasis genes: A progression puzzleNature, 2002
- The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb nodeOncogene, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Predictive Factors for Response to Chemotherapy in Advanced Breast CancerActa Oncologica, 2002
- Cyclin E2, the cycle continuesThe International Journal of Biochemistry & Cell Biology, 2001
- Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell lineNature, 2001
- Tumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight FormsMolecular and Cellular Biology, 2001